BeyondSpring Inc.

1.39-0.1600-10.32%Vol 2.60M1Y Perf -85.91%
Jun 24th, 2022 16:00 DELAYED
BID1.40 ASK1.48
Open1.54 Previous Close1.55
Pre-Market- After-Market1.47
 - -  0.08 5.76%
Target Price
10.77 
Analyst Rating
Hold 2.80
Potential %
674.82 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★     45.67
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
0.82 
Earnings Rating
Neutral
Market Cap42.39M 
Earnings Date
29th Jun 2022
Alpha-0.02 Standard Deviation0.36
Beta1.20 

Today's Price Range

1.391.65

52W Range

1.1333.00

5 Year PE Ratio Range

-22.60-7.40

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
0.00%
1 Month
19.83%
3 Months
-37.39%
6 Months
-71.75%
1 Year
-85.91%
3 Years
-93.31%
5 Years
-96.11%
10 Years
-

TickerPriceChg.Chg.%
BYSI1.39-0.1600-10.32
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
4.80
5.00
0.05
0.13
-742.00
Leverage Ratio 2.00
ProfitabilityValueIndustryS&P 500US Markets
-
-4 778.00
-4 773.50
-
-
RevenueValueIndustryS&P 500US Markets
1.01M
0.03
-
-
Earnings HistoryEstimateReportedSurprise %
Q04 2021--0.24-
Q03 2021-0.58-0.4718.97
Q02 2021-0.49-0.490.00
Q01 2021-0.54-0.4418.52
Q04 2020--0.52-
Q03 2020-0.54-0.4811.11
Q02 2020-0.57-0.4619.30
Q01 2020-0.45-0.58-28.89
Earnings Per EndEstimateRevision %Trend
3/2022 QR-0.2377.88Positive
6/2022 QR-0.2469.62Positive
12/2022 FY-0.95--
12/2023 FY-1.22--
Next Report Date29th Jun 2022
Estimated EPS Next Report-0.23
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume2.60M
Shares Outstanding30.49K
Shares Float23.09M
Trades Count4.86K
Dollar Volume3.66M
Avg. Volume340.88K
Avg. Weekly Volume262.87K
Avg. Monthly Volume430.47K
Avg. Quarterly Volume329.30K

BeyondSpring Inc. (NASDAQ: BYSI) stock closed at 1.39 per share at the end of the most recent trading day (a -10.32% change compared to the prior day closing price) with a volume of 2.60M shares and market capitalization of 42.39M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 61 people. BeyondSpring Inc. CEO is Lan Huang.

The one-year performance of BeyondSpring Inc. stock is -85.91%, while year-to-date (YTD) performance is -69.32%. BYSI stock has a five-year performance of -96.11%. Its 52-week range is between 1.13 and 33, which gives BYSI stock a 52-week price range ratio of 0.82%

BeyondSpring Inc. currently has a PE ratio of -0.80, a price-to-book (PB) ratio of 2.03, a price-to-sale (PS) ratio of 41.84, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -64.60%, a ROC of -104.44% and a ROE of -111.59%. The company’s profit margin is -%, its EBITDA margin is -4 773.50%, and its revenue ttm is $1.01 Million , which makes it $0.03 revenue per share.

Of the last four earnings reports from BeyondSpring Inc., there were 2 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.23 for the next earnings report. BeyondSpring Inc.’s next earnings report date is 29th Jun 2022.

The consensus rating of Wall Street analysts for BeyondSpring Inc. is Hold (2.8), with a target price of $10.77, which is +674.82% compared to the current price. The earnings rating for BeyondSpring Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

BeyondSpring Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

BeyondSpring Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 15.35, ATR14 : 0.22, CCI20 : -23.72, Chaikin Money Flow : -0.29, MACD : -0.02, Money Flow Index : 34.28, ROC : -25.67, RSI : 44.99, STOCH (14,3) : 13.16, STOCH RSI : 0.29, UO : 39.57, Williams %R : -86.84), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of BeyondSpring Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (60.00 %)
3 (60.00 %)
3 (60.00 %)
Moderate Sell
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingHold
2.80
Hold
2.80
Hold
2.80

BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China.

CEO: Lan Huang

Telephone: +1 646 305-6387

Address: 28 Liberty Street, New York 10005, NY, US

Number of employees: 61

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

63%38%

Bearish Bullish

54%46%

TipRanks News for BYSI

Thu, 14 Apr 2022 16:00 GMT Beyondspring (BYSI) Receives a Hold from H.C. Wainwright

- TipRanks. All rights reserved.

Wed, 05 Jan 2022 09:10 GMT Beyondspring (BYSI) Gets a Hold Rating from Dawson James

- TipRanks. All rights reserved.

News

Stocktwits